Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the NRL gene.
Features include common findings: Constriction of peripheral visual field, Undetectable electroretinogram, Bone spicule pigmentation of the retina, and Nyctalopia and others; and sometimes findings: Macular edema and Attenuation of retinal blood vessels. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 5 | Macular edema, Blindness, Visual impairment |
NRL encodes neural retina leucine zipper (237 aa). Acts as a transcriptional activator which regulates the expression of several rod-specific genes, including RHO and PDE6B.
Retinitis pigmentosa 27 is caused by mutations in the NRL gene on chromosome 14.
NRL is classified as a druggable target (Transcription Factor category) with score 0.0.
Genetic testing for NRL is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 27 has been reported in the published literature.
Phenotype severity distribution: 6 common features.
No clinical trials have been registered for retinitis pigmentosa 27.
62 publications have been identified in PubMed for retinitis pigmentosa 27. Research spans Basic Science / Preclinical (34%), Epidemiology / Natural History (27%), and Diagnostic / Biomarker (11%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 21 | 34% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 4:31 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles |
3 |
Peripapillary chorioretinal atrophy, Macular atrophy, Chorioretinal atrophy |
Bones and joints | 1 | Bone spicule pigmentation of the retina |
17 |
27% |
Testing and diagnosis research | 7 | 11% |
Research summaries | 5 | 8% |
New treatment approaches | 5 | 8% |
Patient case studies | 3 | 5% |
Other research | 2 | 3% |
Clinical study results | 2 | 3% |
Hasegawa T (2026). [PMID: 41670415](https://pubmed.ncbi.nlm.nih.gov/41670415/). *Invest Ophthalmol Vis Sci*. [Gene Therapy / Novel Therapeutics]
Daich Varela M (2026). [PMID: 41660487](https://pubmed.ncbi.nlm.nih.gov/41660487/). *Ophthalmol Sci*. [Diagnostic / Biomarker]
Alenazi M (2026). [PMID: 41980014](https://pubmed.ncbi.nlm.nih.gov/41980014/). *Am J Case Rep*. [Case Report / Case Series]
Aychoua N (2026). [PMID: 41296346](https://pubmed.ncbi.nlm.nih.gov/41296346/). *JAMA Ophthalmol*. [Basic Science / Preclinical]
Hong YJ (2026). [PMID: 41457516](https://pubmed.ncbi.nlm.nih.gov/41457516/). *Ann Lab Med*. [Epidemiology / Natural History]
Yang N (2026). [PMID: 41594869](https://pubmed.ncbi.nlm.nih.gov/41594869/). *Biology (Basel)*. [Basic Science / Preclinical]
Fabard M (2026). [PMID: 41686256](https://pubmed.ncbi.nlm.nih.gov/41686256/). *Hum Genet*. [Basic Science / Preclinical]
Romo-Aguas JC (2026). [PMID: 42022048](https://pubmed.ncbi.nlm.nih.gov/42022048/). *Ophthalmol Sci*. [Epidemiology / Natural History]
Stellacci E (2026). [PMID: 41828587](https://pubmed.ncbi.nlm.nih.gov/41828587/). *Int J Mol Sci*. [Basic Science / Preclinical]
Krumpoeck PE (2026). [PMID: 42020935](https://pubmed.ncbi.nlm.nih.gov/42020935/). *Ear Hear*. [Epidemiology / Natural History]